Improving Pediatric COVID-19 Vaccine Awareness, Access, and Accountability in Underrepresented Communities

提高代表性不足社区的儿童 COVID-19 疫苗意识、可及性和责任感

• 批准号: 10399062
• 负责人: Gregory E Hicks
• 金额: $ 28.72万
• 依托单位: UNIVERSITY OF DELAWARE
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-25 至 2023-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10399062
• 关键词: Accountability; Address; Adult; African American; American; Area; Asians; Award; Awareness; Biometry; Budgets; COVID-19 vaccine; Caring; Caucasians; Child Health; Childhood; Clinical Research; Columbidae; Communities; Community Outreach; Delaware; Development; Engineering; Evaluation; Foundations; Funding; Goals; Grant; Growth; Guidelines; Health; Health Promotion; Health system; Healthcare; Healthcare Systems; Hispanics; Hospitals; Infrastructure; Institution; Intention; Lead; Leadership; Letters; Medical; Modeling; Modification; Native Americans; Outreach Research; Pediatric Hospitals; Pilot Projects; Population; Population Heterogeneity; Research; Research Design; Research Personnel; Rural; Scientist; South Carolina; Structure; System; Time; Training; Translational Research; United States National Institutes of Health; Universities; Work; Writing; base; clinical infrastructure; community engagement; epidemiology study; improved; innovation; population health; programs; racial and ethnic; racial diversity; recruit; success; translational research program

Abstract—Overall This proposal is a competitive renewal of the IDeA Program Infrastructure for Clinical and Translational Research (IDeA-CTR)(U54) grant originally awarded in September 2013. The program, titled the Delaware CTR ACCEL Program, has thus currently completed four years of funding at the time of this application. The overall goal of the ACCEL Program remains to provide the key components to allow growth in strategic areas to improve the health of the citizens of Delaware and the nation. Our consortium currently consists of four partners: University of Delaware (UD)—the lead institution; A.I. DuPont Hospital for Children, a part of the Nemours Children’s Health System (Ne- mours); Christiana Care Hospital System (CCHS), the largest health care sys-tem in the state of Delaware; and the Medical University of South Carolina (MUSC), our out-of-state IDeA partner. In this competitive renewal, we will expand our consortium to include Delaware State University (DSU), an American historically black, public univer- sity located in Dover, Delaware. Delaware is an ideal state for a CTR grant as it represents the whole of the USA in a compact form. The population of Delaware (~950,000) mirrors the US population in urban-to-rural citizen ratio and ethnic/racial diversity, with 22% African American, 69% Caucasian, 8% Hispanic, 3% Asian and 1% Native American. The dominance of adult (CCHS) and pediatric (Nemours) hospital systems, which serve at least 85% of the residents of the state, provides a unique opportunity to treat the state of Delaware as a model for examining how healthcare changes can impact population health. Similar to the strong support the ACCEL Program currently enjoys, the part- nering institutions and the State have again agreed to provide over $8.3 M in funds to support ACCEL related activi- ties. The structure and activities of the ACCEL Program have been modified in this competitive renewal. The ACCEL Program now only includes the Administrative Core and the five required key component activities. In addition, based on lessons learned, opportunities discovered, and success achieved, we have made substantive exciting changes to every component of the ACCEL Program. The Overall Specific Aims for the ACCEL Program are to: 1) Provide op- portunities and infrastructure that enhance the ability of outstanding investigators to conduct exciting and impactful clinical and translational research programs in areas of need and opportunity. 2) Recruit, train, and develop clini- cians, scientists, and engineers who will develop innovative, competitive, interdisciplinary, and interinstitutional clin- ical and translational research teams, and 3) Expand and enhance model community engagement outreach research programs that work with the State and other stakeholders to promote health and wellness to a diverse population of Delawareans. The leadership of the ACCEL program is proud of the strong foundation we have created over the past four years and looks forward to continuing to grow clinical and translational research programs that address some of the most important health care needs of Delawareans and all Americans.

摘要——总体 该提案是 IDeA 临床和转化研究计划基础设施的竞争性更新 (IDeA-CTR)(U54) 拨款最初于 2013 年 9 月授予。该计划名为特拉华州 CTR ACCEL 因此，在提出本申请时，该计划目前已完成四年的资助。该项目的总体目标是 ACCEL 计划仍将提供关键组成部分，以实现战略领域的增长，从而改善人们的健康 特拉华州和整个国家的公民。我们的联盟目前由四个合作伙伴组成： 特拉华大学 (UD)——牵头机构；人工智能。杜邦儿童医院是内穆尔儿童健康系统 (Ne- 哀悼）； Christiana Care Hospital System (CCHS)，特拉华州最大的医疗保健系统；和 南卡罗来纳医科大学 (MUSC)，我们的州外 IDeA 合作伙伴。在这次竞争更新中，我们将 扩大我们的联盟，纳入特拉华州立大学 (DSU)，这是一所美国历史悠久的黑人公立大学 城市位于特拉华州多佛市。特拉华州是获得 CTR 资助的理想州，因为它代表了整个美国 紧凑的形式。特拉华州的人口（约 950,000）反映了美国城乡人口比例， 民族/种族多样性，其中 22% 为非洲裔美国人，69% 为白种人，8% 为西班牙裔，3% 为亚洲人，1% 为美洲原住民。 成人 (CCHS) 和儿科 (Nemours) 医院系统占主导地位，为至少 85% 的居民提供服务 该州提供了一个独特的机会，可以将特拉华州视为研究医疗保健如何进行的模型 变化会影响人口健康。与 ACCEL 计划目前获得的大力支持类似，部分—— 培训机构和纽约州再次同意提供超过 830 万美元的资金来支持 ACCEL 相关活动 关系。 ACCEL 计划的结构和活动在本次竞争性更新中进行了修改。加速器 计划现在仅包括管理核心和五个必需的关键组成部分活动。此外， 根据吸取的经验教训、发现的机会和取得的成功，我们做出了令人兴奋的实质性改变 ACCEL 计划的每个组成部分。 ACCEL 计划的总体具体目标是： 1) 提供OP- 提高杰出调查人员进行令人兴奋和有影响力的能力的机会和基础设施 需要和机会领域的临床和转化研究项目。 2) 招募、培训和发展临床医生 科学家、科学家和工程师将开发创新的、有竞争力的、跨学科的和跨机构的临床 学术和转化研究团队，以及 3) 扩大和加强模型社区参与外展研究 与国家和其他利益相关者合作促进不同人群的健康和福祉的计划 特拉华人。 ACCEL 项目的领导层对我们在过去四年中创建的坚实基础感到自豪 并期待继续发展临床和转化研究项目，解决一些问题 特拉华州人和所有美国人最重要的医疗保健需求。